The Directors and Advisors team at Foghorn Therapeutics provides strategic guidance and expert oversight for the company's pioneering efforts in drug discovery and development within the chromatin regulatory system. They leverage their extensive experience to drive the identification and validation of potential drug targets, ensuring the company's proprietary Gene Traffic Control platform is effectively utilized to advance promising therapeutic candidates.
View all